The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Musculoskeletal pain 96
SANDOSTATIN LAR DEPOT Flatulence 95
SANDOSTATIN LAR DEPOT Nasopharyngitis 93
SANDOSTATIN LAR DEPOT Blood glucose increased 91
SANDOSTATIN LAR DEPOT Constipation 91
SANDOSTATIN LAR DEPOT Abdominal discomfort 90
SANDOSTATIN LAR DEPOT Muscle spasms 90
SANDOSTATIN Diarrhoea 88
SANDOSTATIN LAR DEPOT Pneumonia 85
SANDOSTATIN LAR DEPOT Urinary tract infection 84
SANDOSTATIN LAR DEPOT Metastases to liver 83
SANDOSTATIN LAR DEPOT Heart rate increased 82
SANDOSTATIN LAR DEPOT Influenza 82
SANDOSTATIN LAR DEPOT Abdominal distension 80
SANDOSTATIN LAR DEPOT Diabetes mellitus 80
SANDOSTATIN LAR DEPOT Chest pain 79
SANDOSTATIN LAR DEPOT Blood pressure decreased 78
SANDOSTATIN LAR DEPOT Erythema 77
SANDOSTATIN LAR DEPOT Decreased appetite 76
SANDOSTATIN Fatigue 75

Total Records: 2,045     Number of Pages: 103